Compare RANI & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RANI | SLNG |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.9M | 119.0M |
| IPO Year | 2021 | 2019 |
| Metric | RANI | SLNG |
|---|---|---|
| Price | $0.79 | $5.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $7.50 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 482.4K | 38.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.14 | ★ 2400.00 |
| EPS | N/A | ★ N/A |
| Revenue | $1,633,000.00 | ★ $68,245,000.00 |
| Revenue This Year | $274.77 | $8.66 |
| Revenue Next Year | $79.44 | $14.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.45 | $3.21 |
| 52 Week High | $3.87 | $7.07 |
| Indicator | RANI | SLNG |
|---|---|---|
| Relative Strength Index (RSI) | 43.78 | 50.41 |
| Support Level | $0.73 | $3.45 |
| Resistance Level | $0.83 | $5.61 |
| Average True Range (ATR) | 0.05 | 0.47 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 24.61 | 28.60 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.